RecruitingNot applicableNCT05297734
Official study title

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Study summary

This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

Ask AI to explain this study
Start here

Key things to know

Main goalHealth Services Research

This describes the study’s primary purpose.

What is being studiedReceive technology-based supportive cancer care and Receive redesigned team-based supportive cancer care

The study team can explain what participation involves.

Who it may be forEnd of Life · Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Apr 30, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Recruiting

The study is currently accepting participants.

What kind of study?Not applicable

Interventional

Where is it offered?17 U.S. locations

Locations may change over time.

Who runs it?Stanford University

Study sponsor

01
Study overview

What this study is about

Purpose
Health Services Research
Study type
Interventional
Phase
Not applicable
Sponsor
Stanford University
Interventions being studied
Other: Receive technology-based supportive cancer care; Behavioral: Receive redesigned team-based supportive cancer care
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria

1. Newly diagnosed patients with solid tumor cancer diagnosis or recurrence of the disease. 2. Patients must have the ability to understand and willingness to provide verbal consent. 3. Participants must speak English, Spanish, Chinese, or Vietnamese.

Reasons someone may not be able to joinExclusion criteria

1. Inability to consent to the study 2. Plans to change oncologist within 12 months 3. Employed by the practice site 4. Patients who anticipate moving from the area within 12 months

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of Alabama at BirminghamBirmingham, Alabama
  • University of South AlabamaMobile, Alabama
  • Beckman Research Institute of City of HopeDuarte, California
  • VA Medical Center, FresnoFresno, California
  • Santa Clara Valley Medical CenterFruitdale, California
  • St Jude Heritage Medical GroupFullerton, California
  • Oncology Institute for Hope and InnovationLos Angeles, California
  • Sacramento VA Medical Center - VA Northern California Health Care SystemMather, California
  • Pacific Cancer CareMonterey, California
  • VA Palo AltoPalo Alto, California
  • Zuckerberg San Francisco GeneralSan Francisco, California
  • Kaiser Foundation Research InstituteSan Francisco, California

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Apr 30, 2026. Always confirm current availability with the study team.

View original record ↗